Volume 3, Issue 5, Page 8 (May 2007)
9 of 30
PREVIEW
FULL TEXT
FULL-TEXT PDF (66 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
The first generic formulations of the insomnia drug Ambien were approved by the Food and Drug Administration in April, days after the patent on the trade formulation expired.
PII: S1553-3212(07)70151-6
doi:10.1016/S1553-3212(07)70151-6
© 2007 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.